GI Microbiota and Regressive Autism
Gut microbiota had been implicated in regressive autism from vancomycin treatment studies. There is a higher prevalence of abnormal bowel function in autistic children and the non-absorbable vancomycin significantly changes behavior. Presumably, suppressing the culprit bacteria results in improvement. This opens the door to treatment not only with antibiotics, but also with probiotics active against the pathogens, including various forms of fecal microbiota transplantation (FMT).
Thomas Borody, MD, PhD, FRACP, FACP, FACG, AGAF
Prof. Borody is the founder (in 1984) and current Medical Director of the Centre of Digestive Diseases in Sydney, Australia. He has published over 220 scientific papers and was a clinical fellow in Gastroenterology at the Mayo Clinic in Rochester, MN. His research has contributed to antibiotic treatment for Helicobacter pylori in Ulcer Disease and he has continued research into Crohn’s Disease, IBS, and disorders of the human bowel flora. He's championed Faecal Microbiota Transplantation (FMT).
